Comorbidities and respiratory medications in the total COPD cohort (at study start) further split by the MRC dyspnoea grade (first recorded from study start). Hana Müllerová Chao Lu Hao Li Maggie Tabberer 10.1371/journal.pone.0085540.t003 https://plos.figshare.com/articles/dataset/_Comorbidities_and_respiratory_medications_in_the_total_COPD_cohort_at_study_start_further_split_by_the_MRC_dyspnoea_grade_first_recorded_from_study_start_/899268 <p>Percentages are based on row total. Comorbidities were searched for any time in the history before the observation period start; respiratory medications were searched for 12 months prior to study start. MRC scoring 1–5 equals to mMRC grades 0–4 with MRC 1 equals to mMRC 0.</p><p><sup>a</sup>≥4 treatments per year.</p><p>Abbreviations: COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; LABA, long-acting beta-blockers; LAMA, long-acting anticholinergics; MI, myocardial infarction; MRC, Medical Research Council; SABD, short-acting bronchodilators; SD, standard deviation.</p> 2014-01-10 02:44:27 Clinical research design epidemiology Diagnostic medicine pathology Clinical pathology Clinical epidemiology Non-clinical medicine Health care policy Health risk analysis Pulmonology Chronic obstructive pulmonary diseases respiratory medications copd cohort further mrc dyspnoea recorded